Diprospan suspension for injection 1ml/1 ampoule

Composition
active ingredient: betamethasone;

1 ml of suspension contains 6.43 mg of betamethasone dipropionate (equivalent to 5 mg of betamethasone) and 2.63 mg of betamethasone sodium phosphate (equivalent to 2 mg of betamethasone);

excipients:

for ampoules:

sodium hydrogen phosphate, dihydrate; sodium chloride; disodium edetate; polysorbate 80; benzyl alcohol; methyl parahydroxybenzoate (E 218); propyl parahydroxybenzoate (E 216); sodium carboxymethylcellulose; macrogols; hydrochloric acid; water for injections;

Indications
Corticosteroid therapy is an adjunct to, and not an alternative to, conventional treatment.

Dermatological diseases

Atopic dermatitis (moth-like eczema), neurodermatitis, contact dermatitis, severe solar dermatitis, urticaria, lichen planus, insulin-related lipodystrophy, alopecia areata, discoid lupus erythematosus, psoriasis, keloid scars, pemphigus vulgaris, dermatitis herpeticum, cystic acne.

Rheumatic diseases

Rheumatoid arthritis, osteoarthritis, bursitis, tendosynovitis, tendonitis, peritendinitis, ankylosing spondylitis, epicondylitis, radiculitis, coccydynia, sciatica, lumbago, torticollis, ganglion cyst, exostosis, fasciitis, acute gouty arthritis, synovial cysts, Morton’s disease, cuboid inflammation, foot diseases, bursitis on the background of hard corns, spurs, stiffness of the big toe.

Allergic conditions

Bronchial asthma, asthmatic status, hay fever, severe allergic bronchitis, seasonal and aperiodic allergic rhinitis, angioedema, contact dermatitis, atopic dermatitis, serum sickness, hypersensitivity reactions to medications or insect bites.

Collagen diseases

Systemic lupus erythematosus, scleroderma, dermatomyositis, periarteritis nodosa.

Oncological diseases

Palliative therapy of leukemia and lymphoma in adults; acute leukemia in children.

Other diseases

Adrenogenital syndrome, ulcerative colitis, Crohn’s disease, sprue, pathological changes in the blood that require corticosteroid therapy, nephritis, nephrotic syndrome.

Primary and secondary adrenal insufficiency (with mandatory simultaneous administration of mineralocorticoids).